Thor Medical ASA (OSL:TRMED)

Market Cap	1.72B +30.9%
Revenue (ttm)	1.64M +1,539.0%
Net Income	-83.01M
EPS	-0.23
Shares Out	422.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	767,807
Open	4.175
Previous Close	4.100
Day's Range	4.050 - 4.175
52-Week Range	3.485 - 7.120
Beta	0.04
Analysts	Buy
Price Target	5.60 (+37.93%)
Est. Earnings	Nov 27, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 24
• Stock Exchange: Oslo Børs
• Ticker Symbol: TRMED

Analyst Summary

According to 2 analysts, the average rating for TRMED stock is "Buy." The 12-month stock price target is kr 5.60, which is an increase of 37.93% from the latest price.

Price Target

kr 5.60

(37.93% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error